The concentration is publicly identified
The facial estriol page describes an estriol 0.25% preparation and highlights aloe vera extract and vitamin E. It also identifies the product as compounded. Those details should be attached to the particular facial cream, rather than to every hormone treatment available through Evernow.
A concentration comparison is not an effectiveness ranking. A cream labeled 0.25% should not automatically be called weaker in practice or more suitable for sensitive skin than a different finished formulation labeled 0.3%. The base, application instructions and clinical circumstances also matter, and direct comparative evidence would be needed for a reliable outcome claim.
Evernow describes its base as hypoallergenic. That is a provider description, not a guarantee that no user can react. Request the complete ingredient list and discuss previous reactions with the clinician. Our claims guide explains why a reassuring adjective still needs a defined meaning and an appropriate evidence boundary.
The $35 figure describes care
The public pages showed a membership starting at $35 per month. The surrounding copy identifies it as a care-access option, not a confirmed all-inclusive price for a bottle of facial estriol. We could not establish a current standalone medicine price from the product and membership records reviewed.
Evernow also advertises a pay-per-visit pathway. Its membership page distinguishes that option from ongoing membership and describes the access each includes. A prospective patient should ask which route is available for the intended prescription and what separate charges apply to the medicine.
This is why the price workspace does not display $35 as Evernow’s cream price. It labels the figure as a starting care fee and leaves the medication cost unresolved. Filling that gap with an old review or a figure from a search snippet would create a false comparison with a clearly priced supply from another provider.
A discount comparison needs its basis
Evernow’s page makes a broad claim that its facial estriol costs less than other brands. We did not independently substantiate that comparison because the current medicine price, included services and comparison set were not fully established in the reviewed offer. We therefore do not use the claim to rank it by total cost.
Ask for the medication amount, dispensing quantity, refill period, care charge and any other required payment in the same written estimate. Also ask whether the first period differs from later periods. Only then can a meaningful comparison be made with Winona’s three-month offer or Wisp’s 90-day supply.
The price guide explains the difference between normalizing a known supply amount and estimating an unknown total. It is reasonable for a quote to require clinical evaluation. It is not reasonable for a review to pretend that an unconfirmed number is already known.
Care access and medicine coverage are separate
Evernow describes both insurance-eligible video visits and self-pay or membership arrangements. Those statements concern the service’s available payment pathways. They do not establish that a particular insurance plan covers this compounded facial prescription, a specific consultation or every optional service.
Confirm coverage directly for the service and medication being considered. FSA or HSA payment eligibility also should not be treated as a guarantee of insurance reimbursement. These distinctions can materially change an apparent monthly comparison even when the headline numbers seem straightforward.
The provider describes ongoing messaging and personalized care plans. Ask how follow-up for the facial cream works, who answers clinical questions and whether a change to the preparation carries an additional charge. A broad care service can be relevant to a reader, but its wider offering should not be assumed necessary or included without checking.
The clinical claims remain qualified
Evernow’s public description discusses collagen, elasticity, hydration and skin appearance. These are provider claims. We did not identify a trial of the exact facial formulation in the materials reviewed, and testimonials on the page do not supply that missing experimental comparison.
The product FAQ explicitly explains that the compounded preparation has not been evaluated through FDA approval for safety or effectiveness. The FDA’s own guidance states that no estriol-containing drugs are FDA-approved. Its compounding overview supplies the broader regulatory context.
Tell the clinician about other hormone products and relevant medical history. A facial application or a lower advertised concentration does not, by itself, establish zero systemic exposure or suitability for every user. The proposed treatment should be considered as part of the complete medication picture.
The useful next step is a complete quote
Evernow makes the active concentration and care-access choices visible. The major gap for a purchase comparison is the current medication price together with the chosen care pathway. A useful response from the provider would identify both, rather than leaving the reader to combine figures from unrelated pages.
Compare the confirmed details with the sponsored CoreAge Rx review and the four-offer overview. Use our prescription checklist to keep formulation, clinical evaluation and billing questions together. A more complete record may support a purchase, a different option or a decision to seek further assessment first.